{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:10:07Z","timestamp":1758708607491,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,24]]},"DOI":"10.7759\/cureus.93087","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:52:11Z","timestamp":1758707531000},"source":"Crossref","is-referenced-by-count":0,"title":["Cystathionine Detection via Proton Magnetic Resonance Spectroscopy (\u00b9H-MRS) for the Diagnosis of Oligodendroglioma: A Case Report"],"prefix":"10.7759","author":[{"given":"Tomoka","family":"Nakashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Momosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaoki","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Hatae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Otsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Hashisako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Togao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousei","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO classification of tumours. (2022). Accessed. August 23, 2025: https:\/\/tumourclassification.iarc.who.int\/welcome\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-022-03008-6","article-title":"2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist","volume":"64","author":"McNamara C","year":"2022","unstructured":"McNamara C, Mankad K, Thust S, et al.. 2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist. Neuroradiology. 2022, 64:1919-50. 10.1007\/s00234-022-03008-6","journal-title":"Neuroradiology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13062","article-title":"Classification of adult-type diffuse gliomas: impact of the World Health Organization 2021 update","volume":"32","author":"Whitfield BT","year":"2022","unstructured":"Whitfield BT, Huse JT. Classification of adult-type diffuse gliomas: impact of the World Health Organization 2021 update. Brain Pathol. 2022, 32:e13062. 10.1111\/bpa.13062","journal-title":"Brain Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28743","article-title":"The 2021 WHO classification for gliomas and implications on imaging diagnosis: part 1-key points of the fifth edition and summary of imaging findings on adult-type diffuse gliomas","volume":"58","author":"Park YW","year":"2023","unstructured":"Park YW, Vollmuth P, Foltyn-Dumitru M, Sahm F, Ahn SS, Chang JH, Kim SH. The 2021 WHO classification for gliomas and implications on imaging diagnosis: part 1-key points of the fifth edition and summary of imaging findings on adult-type diffuse gliomas. J Magn Reson Imaging. 2023, 58:677-89. 10.1002\/jmri.28743","journal-title":"J Magn Reson Imaging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0002","article-title":"NCCN Guidelines\u00ae insights: central nervous system cancers, version 2.2022","volume":"21","author":"Horbinski C","year":"2023","unstructured":"Horbinski C, Nabors LB, Portnow J, et al.. NCCN Guidelines\u00ae insights: central nervous system cancers, version 2.2022. J Natl Compr Canc Netw. 2023, 21:12-20. 10.6004\/jnccn.2023.0002","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0052","article-title":"Central nervous system cancers, version 3.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Nabors LB","year":"2020","unstructured":"Nabors LB, Portnow J, Ahluwalia M, et al.. Central nervous system cancers, version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020, 18:1537-70. 10.6004\/jnccn.2020.0052","journal-title":"J Natl Compr Canc Netw"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-002-1547-3","article-title":"Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization","volume":"13","author":"Maj\u00f3s C","year":"2003","unstructured":"Maj\u00f3s C, Alonso J, Aguilera C, et al.. Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol. 2003, 13:582-91. 10.1007\/s00330-002-1547-3","journal-title":"Eur Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.223255","article-title":"Neurochemical differences between 1p\/19q codeleted and noncodeleted IDH-mutant gliomas by in vivo MR spectroscopy","volume":"308","author":"Branzoli F","year":"2023","unstructured":"Branzoli F, Liserre R, Deelchand DK, et al.. Neurochemical differences between 1p\/19q codeleted and noncodeleted IDH-mutant gliomas by in vivo MR spectroscopy. Radiology. 2023, 308:e223255. 10.1148\/radiol.223255","journal-title":"Radiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-023-03186-x","article-title":"Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p\/19q-codeletion status in diffuse gliomas without intense contrast enhancement","volume":"65","author":"Yamashita K","year":"2023","unstructured":"Yamashita K, Togao O, Kikuchi K, et al.. Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p\/19q-codeletion status in diffuse gliomas without intense contrast enhancement. Neuroradiology. 2023, 65:1415-8. 10.1007\/s00234-023-03186-x","journal-title":"Neuroradiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher SW","year":"1993","unstructured":"Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993, 30:672-9. 10.1002\/mrm.1910300604","journal-title":"Magn Reson Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb32915.x","article-title":"Spatial localization in NMR spectroscopy in vivo","volume":"508","author":"Bottomley PA","year":"1987","unstructured":"Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 1987, 508:333-48. 10.1111\/j.1749-6632.1987.tb32915.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.26826","article-title":"Transverse relaxation time constants of the five major metabolites in human brain measured in vivo using LASER and PRESS at 3 T","volume":"79","author":"Deelchand DK","year":"2018","unstructured":"Deelchand DK, Auerbach EJ, Kobayashi N, Marja\u0144ska M. Transverse relaxation time constants of the five major metabolites in human brain measured in vivo using LASER and PRESS at 3 T. Magn Reson Med. 2018, 79:1260-5. 10.1002\/mrm.26826","journal-title":"Magn Reson Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.713","article-title":"Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla","volume":"14","author":"Mlyn\u00e1rik V","year":"2001","unstructured":"Mlyn\u00e1rik V, Gruber S, Moser E. Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed. 2001, 14:325-31. 10.1002\/nbm.713","journal-title":"NMR Biomed"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-198601000-00006","article-title":"Oligodendroglioma. Histologic evaluation and prognosis","volume":"45","author":"M\u00f8rk SJ","year":"1986","unstructured":"M\u00f8rk SJ, Halvorsen TB, Lindegaard KF, Eide GE. Oligodendroglioma. Histologic evaluation and prognosis. J Neuropathol Exp Neurol. 1986, 45:65-78. 10.1097\/00005072-198601000-00006","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20150857","article-title":"Imaging of oligodendroglioma","volume":"89","author":"Smits M","year":"2016","unstructured":"Smits M. Imaging of oligodendroglioma. Br J Radiol. 2016, 89:20150857. 10.1259\/bjr.20150857","journal-title":"Br J Radiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0353-z","article-title":"Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion","volume":"103","author":"Choi KY","year":"2011","unstructured":"Choi KY, Jung TY, Jung S, et al.. Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion. J Neurooncol. 2011, 103:103-10. 10.1007\/s11060-010-0353-z","journal-title":"J Neurooncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050678","article-title":"The non-essential amino acid cysteine becomes essential for tumor proliferation and survival","volume":"11","author":"Combs JA","year":"2019","unstructured":"Combs JA, DeNicola GM. The non-essential amino acid cysteine becomes essential for tumor proliferation and survival. Cancers (Basel). 2019, 11:678. 10.3390\/cancers11050678","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz031","article-title":"Cystathionine as a marker for 1p\/19q codeleted gliomas by in vivo magnetic resonance spectroscopy","volume":"21","author":"Branzoli F","year":"2019","unstructured":"Branzoli F, Pontoizeau C, Tchara L, et al.. Cystathionine as a marker for 1p\/19q codeleted gliomas by in vivo magnetic resonance spectroscopy. Neuro Oncol. 2019, 21:765-74. 10.1093\/neuonc\/noz031","journal-title":"Neuro Oncol"},{"key":"ref19","article-title":"In vivo proton MR spectroscopy reveals alterations in cysteine metabolism in human gliomas","author":"Chan K","year":"2025","unstructured":"Chan K, Noch EK, Maher E, et al.. In vivo proton MR spectroscopy reveals alterations in cysteine metabolism in human gliomas. Proceedings of the Annual Meeting of International Society for Magnetic Resonance in Medicine (ISMRM). Hawaii, USA; 2025."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8413","article-title":"Incorporation of edited MRS into clinical practice may improve care of patients with IDH-mutant glioma","volume":"46","author":"Nichelli L","year":"2025","unstructured":"Nichelli L, Cadin C, Lazzari P, et al.. Incorporation of edited MRS into clinical practice may improve care of patients with IDH-mutant glioma. AJNR Am J Neuroradiol. 2025, 46:113-20. 10.3174\/ajnr.A8413","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411341-cystathionine-detection-via-proton-magnetic-resonance-spectroscopy-h-mrs-for-the-diagnosis-of-oligodendroglioma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:52:12Z","timestamp":1758707532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411341-cystathionine-detection-via-proton-magnetic-resonance-spectroscopy-h-mrs-for-the-diagnosis-of-oligodendroglioma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.93087","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}